Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 9,478 | 2,473 | 4,733 | 5,561 | 1,229 |
| Other current assets | 0 | 0 | 71 | 0 | 0 |
| TOTAL | $9,698 | $2,768 | $5,131 | $5,816 | $1,280 |
| Non-Current Assets | |||||
| PPE Net | 2,034 | 2,361 | 2,645 | 3,045 | 3,511 |
| Intangibles | 1,676 | 1,676 | 1,676 | 1,676 | 0 |
| Other Non-Current Assets | 12 | 12 | 2,027 | 27 | 12 |
| TOTAL | $3,721 | $4,048 | $6,348 | $4,747 | $3,522 |
| Total Assets | $13,420 | $6,816 | $11,478 | $10,563 | $4,802 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 934 | 1,162 | 717 | 478 | 393 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 305 |
| Other current liabilities | 5,177 | 3,359 | 13 | 23 | N/A |
| TOTAL | $6,233 | $4,523 | $733 | $504 | $905 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 478 | 593 | 585 | 574 | 3,757 |
| TOTAL | $489 | $593 | $587 | $579 | $3,764 |
| Total Liabilities | $6,722 | $5,116 | $1,320 | $1,082 | $4,668 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 0 | 57,398 | 57,398 | 36,908 | N/A |
| Common Shares | 0 | 0 | 1 | 0 | 0 |
| Retained earnings | -59,112 | -51,060 | -40,277 | -31,480 | -24,045 |
| TOTAL | $6,698 | $1,700 | $10,158 | $9,481 | $134 |
| Total Liabilities And Equity | $13,420 | $6,816 | $11,478 | $10,563 | $4,802 |